{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:22:52Z","timestamp":1790007772402,"version":"4.0.1"},"reference-count":44,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.3892\/or.2014.3106","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T13:53:47Z","timestamp":1395410027000},"page":"2021-2028","source":"Crossref","is-referenced-by-count":65,"title":["miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma"],"prefix":"10.3892","volume":"31","author":[{"given":"FEI","family":"GUO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID","family":"COGDELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIMEI","family":"HU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DA","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANIL K.","family":"SOOD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FENGXIA","family":"XUE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"key":"key20180107222448_b1-or-31-05-2021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 2","key":"key20180107222448_b2-or-31-05-2021","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0020-7292(12)60025-3","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"119","author":"Berek","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"key20180107222448_b3-or-31-05-2021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20180107222448_b4-or-31-05-2021","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1073\/pnas.1214547110","article-title":"Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle","volume":"110","author":"Arvizo","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107222448_b5-or-31-05-2021","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2013.03.019","article-title":"Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells","volume":"130","author":"Gupta","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key20180107222448_b6-or-31-05-2021","doi-asserted-by":"crossref","first-page":"e54362","DOI":"10.1371\/journal.pone.0054362","article-title":"The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells","volume":"8","author":"Ford","year":"2013","journal-title":"PLoS One"},{"key":"key20180107222448_b7-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1158\/0008-5472.CAN-12-2377","article-title":"ALX1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of ovarian cancer cells","volume":"73","author":"Yuan","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107222448_b8-or-31-05-2021","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/jhg.2013.31","article-title":"Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma","volume":"58","author":"Yoshino","year":"2013","journal-title":"J Hum Genet"},{"key":"key20180107222448_b9-or-31-05-2021","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2010.12.339","article-title":"Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells","volume":"121","author":"Chen","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107222448_b10-or-31-05-2021","doi-asserted-by":"crossref","first-page":"506731","DOI":"10.1155\/2013\/506731","article-title":"miR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1","volume":"2013","author":"Ke","year":"2013","journal-title":"Biochem Res Int"},{"key":"key20180107222448_b11-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/liv.12190","article-title":"MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition","volume":"33","author":"Zhou","year":"2013","journal-title":"Liver Int"},{"key":"key20180107222448_b12-or-31-05-2021","doi-asserted-by":"crossref","first-page":"e62757","DOI":"10.1371\/journal.pone.0062757","article-title":"miR-655 is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2","volume":"8","author":"Harazono","year":"2013","journal-title":"PLoS One"},{"key":"key20180107222448_b13-or-31-05-2021","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"key20180107222448_b14-or-31-05-2021","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1593\/neo.121828","article-title":"Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression","volume":"15","author":"Paterson","year":"2013","journal-title":"Neoplasia"},{"key":"key20180107222448_b15-or-31-05-2021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","article-title":"miRNAs, cancer, and stem cell division","volume":"122","author":"Croce","year":"2005","journal-title":"Cell"},{"key":"key20180107222448_b16-or-31-05-2021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20180107222448_b17-or-31-05-2021","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev"},{"key":"key20180107222448_b18-or-31-05-2021","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","article-title":"Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer","volume":"23","author":"Yang","year":"2013","journal-title":"Cancer Cell"},{"key":"key20180107222448_b19-or-31-05-2021","doi-asserted-by":"crossref","first-page":"e64273","DOI":"10.1371\/journal.pone.0064273","article-title":"miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines","volume":"8","author":"Arora","year":"2013","journal-title":"PLoS One"},{"key":"key20180107222448_b20-or-31-05-2021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.4032","article-title":"Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer","volume":"228","author":"Carvalho","year":"2012","journal-title":"J Pathol"},{"key":"key20180107222448_b21-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1165395","article-title":"Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer","volume":"322","author":"Varambally","year":"2008","journal-title":"Science"},{"key":"key20180107222448_b22-or-31-05-2021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/path.4097","article-title":"Loss of miR-101 expression promotes Wnt\/\u03b2-catenin signalling pathway activation and malignancy in colon cancer cells","volume":"229","author":"Strillacci","year":"2013","journal-title":"J Pathol"},{"key":"key20180107222448_b23-or-31-05-2021","first-page":"855","article-title":"The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma","volume":"123","author":"Parker","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180107222448_b24-or-31-05-2021","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.1120375109","article-title":"Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-\u03baB network","volume":"109","author":"Holmes","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107222448_b25-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.7150\/ijbs.4458","article-title":"DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis","volume":"8","author":"Zhang","year":"2012","journal-title":"Int J Biol Sci"},{"key":"key20180107222448_b26-or-31-05-2021","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2407-13-216","article-title":"MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples","volume":"13","author":"Li","year":"2013","journal-title":"BMC Cancer"},{"key":"key20180107222448_b27-or-31-05-2021","doi-asserted-by":"crossref","first-page":"e21730","DOI":"10.1371\/journal.pone.0021730","article-title":"MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone","volume":"6","author":"Cui","year":"2011","journal-title":"PLoS One"},{"key":"key20180107222448_b28-or-31-05-2021","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2013.04.042","article-title":"MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met","volume":"435","author":"Hu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107222448_b29-or-31-05-2021","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/annonc\/mds513","article-title":"The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms","volume":"24","author":"Caponi","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180107222448_b30-or-31-05-2021","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s11095-011-0547-x","article-title":"MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21waf1\/cip1","volume":"28","author":"Semaan","year":"2011","journal-title":"Pharm Res"},{"key":"key20180107222448_b31-or-31-05-2021","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4161\/cc.9.5.10839","article-title":"ZEB proteins link cell motility with cell cycle control and cell survival in cancer","volume":"9","author":"Browne","year":"2010","journal-title":"Cell Cycle"},{"key":"key20180107222448_b32-or-31-05-2021","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00018-008-8465-8","article-title":"The role of the ZEB family of transcription factors in development and disease","volume":"66","author":"Vandewalle","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"key20180107222448_b33-or-31-05-2021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180107222448_b34-or-31-05-2021","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1158\/0008-5472.CAN-05-2881","article-title":"The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers","volume":"66","author":"Spoelstra","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107222448_b35-or-31-05-2021","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/ijc.22083","article-title":"The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas","volume":"119","author":"Pena","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180107222448_b36-or-31-05-2021","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/sj.onc.1210012","article-title":"Collagen type I- induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer","volume":"26","author":"Imamichi","year":"2007","journal-title":"Oncogene"},{"key":"key20180107222448_b37-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/cncr.20946","article-title":"Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma","volume":"103","author":"Elloul","year":"2005","journal-title":"Cancer"},{"key":"key20180107222448_b38-or-31-05-2021","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00428-006-0274-6","article-title":"Expression of E-cadherin transcriptional regulators in ovarian carcinoma","volume":"449","author":"Elloul","year":"2006","journal-title":"Virchows Arch"},{"key":"key20180107222448_b39-or-31-05-2021","doi-asserted-by":"crossref","first-page":"e2436","DOI":"10.1371\/journal.pone.0002436","article-title":"MicroRNA expression and identification of putative miRNA targets in ovarian cancer","volume":"3","author":"Dahiya","year":"2008","journal-title":"PLoS One"},{"key":"key20180107222448_b40-or-31-05-2021","doi-asserted-by":"crossref","first-page":"e47709","DOI":"10.1371\/journal.pone.0047709","article-title":"MicroRNA-200 family modulation in distinct breast cancer phenotypes","volume":"7","author":"Castilla","year":"2012","journal-title":"PLoS One"},{"key":"key20180107222448_b41-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/gutjnl-2011-301846","article-title":"MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis","volume":"62","author":"Hur","year":"2012","journal-title":"Gut"},{"key":"key20180107222448_b42-or-31-05-2021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cellsig.2012.10.013","article-title":"miR-101 is down-regulated by the hepatitis B virus \u00d7 protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A","volume":"25","author":"Wei","year":"2013","journal-title":"Cell Signal"},{"key":"key20180107222448_b43-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/carcin\/bgq150","article-title":"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients","volume":"31","author":"Rao","year":"2010","journal-title":"Carcinogenesis"},{"key":"key20180107222448_b44-or-31-05-2021","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/0008-5472.CAN-06-3700","article-title":"Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3106\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T07:23:16Z","timestamp":1716621796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,21]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,3,21]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.3892\/or.2014.3106"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3106","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,21]]}}}